1. Home
  2. FRMM vs FLNA Comparison

FRMM vs FLNA Comparison

Compare FRMM & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$4.62

Market Cap

75.7M

Sector

Health Care

ML Signal

N/A

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.81

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRMM
FLNA
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.7M
61.8M
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
FRMM
FLNA
Price
$4.62
$0.81
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
119.0K
226.1K
Earning Date
05-26-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,547,000.00
$41,119,000.00
Revenue This Year
$183.55
N/A
Revenue Next Year
$166.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$0.75
52 Week High
$7.15
$2.03

Technical Indicators

Market Signals
Indicator
FRMM
FLNA
Relative Strength Index (RSI) 35.58 28.28
Support Level $3.61 N/A
Resistance Level $5.37 $0.99
Average True Range (ATR) 0.38 0.05
MACD -0.12 -0.01
Stochastic Oscillator 6.46 11.30

Price Performance

Historical Comparison
FRMM
FLNA

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: